TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EXOZ

eXoZymes, Inc.

Healthcare · Biotechnology

6.40$ +4.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement EXOZ
Line item 2021 2022 2023 2024 2025
+148.7%
-23.4% +51.5% +254.3% +98.4%
+17.4% +36.0% +203.5% +45.5%
-3.9% +51.6% +215.4% +71.5%
-33.5%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?